A nonprofit patient advocacy group, Psoriasis Cure Now, has urged a joint hearing of two Food and Drug Administration Advisory Committees to approve OTC use of certain topical steroids that presently require a prescription.
Topical corticosteroids are instrumental to treat as many as 6.5 million American afflicted with psoriasis and over-the-counter status of these steroids could result in reduced cost and enhanced convenience.
Specific topical steroids that presently require a prescription could be safely and effectively used by psoriasis patients in an over-the-counter setting, according to Michael Paranzino, President of Psoriasis Cure Now.
